CoagulationDisorders near Yonkers, NY

Biography: Manuela Orjuela-Grimm is a molecular epidemiologist and pediatric oncologist whose research focuses on vulnerability (including social) to environmental exposures, gene-nutrient/ environment interactions during windows of susceptibility such as pregnancy, early childhood, adolescence and the development of later genetic and epigenetic changes contributing to poorer health outcomes in childhood and adolescence. She leads EpiRbMx, a long-standing case control/ case series study examining exposure to methyl donors, folate pathway metabolism and risk for retinoblastoma in collaboration with a multidisciplinary team of investigators including the Hospital Infantil de Mexico, the Hospital de Pediatria at the Instituto Mexicano de Seguro Social (IMSS), the Instituto Nacional de Salud Publica (INSP), and the University of Toronto. In collaboration with INSP researchers, Dr. Orjuela is involved in multiple studies examining the intersection between food security, folate-related dietary intake, dietary diversity and environmental exposures in central Mexico, and in immigrants in New York. Interests: social contributors to dietary exposures, gene-nutrient interactions; one carbon donor metabolism; methylation; nutrient and environmental exposures during early life and later genetic and epigenetic effects; dietary assessment in Mexico, in populations on the move in Latin America; effects of acculturation and early life migration on nutrient/ environmental exposures in US Latinos.

Biography: Originally from Columbus, OH, SunilIyercompleted his undergraduate studies at Washington University in St. Louis. He then completed his medical education and training at the University of Miami, where he served as chief hematology/oncology fellow. He has a strong interest in leukemia, particularly in the genomics and treatment of acute lymphoblastic leukemia.

Biography: After earning a medical degree from Yale University School of Medicine, Dr. Overton completed both her residency and her fellowship in Maternal-Fetal Medicine at NewYork-Presbyterian Columbia University Irving Medical Center (CUIMC). Dr. Overton's clinical and research interests include placenta accreta spectrum disorder, management and prevention of obstetric surgical complications, care of patients with prior poor obstetric outcomes and preterm birth prevention. She has ample experience and training in diagnostic ultrasound screening and procedural testing, including amniocentesis and chorionic villus sampling.

Biography: Dr. Sheen is the Medical Director of Labor and Delivery at NewYork-Presbyterian/Columbia University Irving Medical Center. She entered the field of maternal-fetal medicine after an established career in general obstetrics and gynecology and education, having received her medical degree from the New York University School of Medicine and followed with residency training in obstetrics and gynecology at NewYork-Presbyterian Hospital/Weill Cornell Medical College. She then practiced general obstetrics and gynecology and was the Associate Residency Director at Jamaica Hospital Medical Center prior to pursuing her fellowship in Maternal-Fetal Medicine (MFM) at Albert Einstein College of Medicine/Montefiore Medical Center. Her experience with varying maternal medical and fetal disorders contributed to her interest in pursuing formal training in perinatology. During fellowship, Dr. Sheen continued her work with maternal medical disorders, obstetrics and gynecology education, patient safety and the quality assessment of patient care, besides developing her interests in evaluating fetal anomalies. Her research and interests have included studies of progesterone use in preventing preterm labor in patients with varying medical co-morbidities, radiologic imaging for evaluating pulmonary emboli in pregnancy, postpartum emergency room utilization, epigenetics of diabetes and obesity, as well as patient safety and resident education through simulation/hand-off training.

Biography: Dr. Stergios Zacharoulis, MD is a Hematology Specialist who practices in New York, NY. He is 55 years old and has been practicing for 30 years. Dr. Stergios Zacharoulis, MD is affiliated with Newyork-Presbyterian/Morgan Stanley Children's Hospital and Newyork-Presbyterian/Columbia University Medical Center.

Biography: Lisa Nathan, MD, MPH is theChief of Obstetrics, Sloane Hospital for Women, Columbia University Irving Medical Center and an Associate Professor of Obstetrics & Gynecology in the Department of Obstetrics and Gynecology at CUMC. She completed her Ob/Gyn residency training at Montefiore/Einstein and stayed on to work for several years as an academic generalist. During this time, she founded the Global Women's Health Program for the Department with grant support from the Einstein Global Health Center and the U.S. Fulbright African Regional Research Program. Dr. Nathan also founded Einstein's Departmental Health Equity Task Force. The goal of this task force was to create a Departmental culture and workforce that understands the concepts of health disparities and structural racism, recognizes the ways in which society and the health system promote them, and works proactively to dismantle them. In addition to her clinical and administrative duties, Dr Nathan is also active within ACOG, where she is a member of the Safe Motherhood Initiative Steering Committee. She was the Chair of the Maternal Sepsis Bundle workgroup and is a current member of the Health Equity Subcommittee. She also serves as a consultant to the New York City Department of Health, where she serves as the Co-Chair of the Maternal Mortality Review Committee. In this role, she reviews events leading to maternal mortality for the majority of cases occurring in New York City. These reviews form the basis for the development of recommendations for city and state level initiatives to combat the root causes of the high maternal mortality rates in New York City.

Biography: Meghna S. Trivedi, MD, MS cares for patients diagnosed with breast cancer. Dr. Trivedi received her medical degree from the University of Maryland School of Medicine, and completed her residency at the University of Pennsylvania. She went on to complete her fellowship in hematology/oncology at Columbia University. Dr. Trivedi co-leads the Hereditary Breast and Ovarian Cancer Program, a comprehensive, multi-disciplinary initiative aimed at screening, preventing, diagnosing, and treating hereditary breast and ovarian cancer. This innovative program brings together the resources of a world-renowned academic institution, including cutting-edge genomic testing, clinical trials, and experts in hereditary cancers across different specialties. Dr. Trivedi's research and care expertise also includes cancer genetics and genomics, precision medicine, and chemotherapy induced peripheral neuropathy. She is the principal investigator on several clinical trials, and has authored numerous publications in leading peer-reviewed journals. Dr. Trivedi is a member of the American Society of Clinical Oncologists and SWOG.

Biography: Dr. Joel Gabre, MD is an Oncology Specialist who practices in New York, NY. He is 39 years old and has been practicing for 13 years. Dr. Joel Gabre, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center.

Biography: Mariam El-Ashmawy, MD PhD is a medical oncologist andtranslational scientist with specialization in the treatment of advanced skincancer and ocular melanoma. Her research investigates the complex geneticlandscape of cancer in order to develop new therapies. In the laboratory, her work has been dedicated to understanding the complex genomic landscape of cancer and developing novel targeted therapeutic strategies. Her ongoing projects include testing novel RAS pathway inhibitors in preclinical models of gastric and esophageal cancer as well as a first-in-human clinical trials for patients with NRAS mutant melanoma.

Biography: Dr. Henick is a medical oncologist specializing in the care of patients with malignancies of the aerodigestive tract.As the Associate Director of Experimental Therapeutics and Director of Translational Research in Aerodigestive Cancers in Medical Oncology, Dr. Henick's clinical care and research are aligned to improve the effectiveness of, and limit toxicity from, emerging cancer treatments. These effortsentail clinical trials that Dr. Henick has written and leads to study novel therapeutic approaches and to reduce steroid dependence among patients experiencing adverse events fromimmunotherapy.